nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute cholecystitis due to gallbladder metastasis of a gastric diffuse adenocarcinoma
|
de Tomás, J. |
|
2018 |
92 |
S2 |
p. S7 |
artikel |
2 |
Analysis of protein overexpression and Her2 gene amplification in gastric adenocarcinoma from Moroccan patients
|
Fahmi, L. |
|
2018 |
92 |
S2 |
p. S6-S7 |
artikel |
3 |
Author index
|
|
|
2018 |
92 |
S2 |
p. I |
artikel |
4 |
Comparison of 3DCRT and VMAT treatment in neoadjuvant oesophageal cancer
|
Cruz, O. Santa |
|
2018 |
92 |
S2 |
p. S5-S6 |
artikel |
5 |
Contents
|
|
|
2018 |
92 |
S2 |
p. iv |
artikel |
6 |
D2-lymphadenectomy and gastric resection in a consecutive series of patients with gastric cancer
|
Chiappa, A. |
|
2018 |
92 |
S2 |
p. S7 |
artikel |
7 |
Endoscopic approach to signet cell cancer
|
Seewald, S. |
|
2018 |
92 |
S2 |
p. S4 |
artikel |
8 |
FLOT, MAGIC or CROSS for adenocarcinoma of the oesophagus and cardia?
|
Smyth, E. |
|
2018 |
92 |
S2 |
p. S2-S3 |
artikel |
9 |
Hereditary gastric cancer
|
Carneiro, F. |
|
2018 |
92 |
S2 |
p. S4 |
artikel |
10 |
K-RAS mutation in gastric cancer and its link with microsatellite instability status
|
Roviello, F. |
|
2018 |
92 |
S2 |
p. S6 |
artikel |
11 |
Management, short and long-term outcomes in septegenerians and octegenerians undergoing gastrectomy for cancer
|
Mengardo, V. |
|
2018 |
92 |
S2 |
p. S7-S8 |
artikel |
12 |
Neoadjuvant phase II trial of chemo-radiotherapy (CRT) in patients with resectable (R) and borderline resectable (BR) pancreatic ductal adenocarcinoma (PDA)
|
Damarla, V. |
|
2018 |
92 |
S2 |
p. S8-S9 |
artikel |
13 |
Oesophago-gastric cancer: One disease or separate entities?
|
Laurent-Puig, P. |
|
2018 |
92 |
S2 |
p. S1 |
artikel |
14 |
Patterns of recurrence to guide selection of multi-modal treatment
|
Verheij, M. |
|
2018 |
92 |
S2 |
p. S2 |
artikel |
15 |
Perioperative treatment strategies and current studies to improve gastric cancer outcomes in Japan
|
Terashima, M. |
|
2018 |
92 |
S2 |
p. S3 |
artikel |
16 |
Potential impact of molecular classification on tailored lymphadenectomy for gastric cancer
|
Roviello, F. |
|
2018 |
92 |
S2 |
p. S8 |
artikel |
17 |
Preoperative chemoradiation in upper rectal cancer: A retrospective analysis of our recent data
|
Gallarín, M. Caro |
|
2018 |
92 |
S2 |
p. S9 |
artikel |
18 |
Quality assurance in upper GI cancer
|
Allum, W. |
|
2018 |
92 |
S2 |
p. S5 |
artikel |
19 |
Response-adapted treatment stratification in oesophago-gastric cancer
|
Lordick, F. |
|
2018 |
92 |
S2 |
p. S3 |
artikel |
20 |
Signet ring cell carcinoma in the stomach: Histopathological definitions and response to therapy assessment – The urgent need for an international consensus
|
Grabsch, H.I. |
|
2018 |
92 |
S2 |
p. S3-S4 |
artikel |
21 |
Stomach cancer in Morocco: an 11-year retrospective study
|
Haimer, A. |
|
2018 |
92 |
S2 |
p. S8 |
artikel |
22 |
The amount of cells with Signet Ring Cell morphology has a prognostic impact in poorly cohesive gastric carcinoma
|
Bencivenga, M. |
|
2018 |
92 |
S2 |
p. S6 |
artikel |
23 |
The role of HIPEC in gastric cancer
|
Roviello, F. |
|
2018 |
92 |
S2 |
p. S4-S5 |
artikel |
24 |
What imaging is needed to select patients for neoadjuvant treatment and where are the limitations?
|
Riddell, A.M. |
|
2018 |
92 |
S2 |
p. S1-S2 |
artikel |